Overview
Koninklijke Philips N.V.
The company lights up the healthcare world with medical and health products ranging from MRI and CT scanners to electric toothbrushes. The company's lineup includes instruments for disease diagnosis, treatment, and management including imaging systems, home healthcare equipment, and clinical IT management products. Also known as Philips, it also makes a range of personal care products that include connected devices for preventive care and managing
...
Read More chronic illness. The Dutch company, which generates most of its sales outside its home country, traces its roots to 1891.
Read Less
Read More chronic illness. The Dutch company, which generates most of its sales outside its home country, traces its roots to 1891.
Read Less
F. A. van Houten
See more contacts
Management of Companies and Enterprises
,
Holding companies, nec
High Tech Campus 52 5656 AG, Eindhoven, NOORD-BRABANT Netherlands
See other locations
+31-402791111
14
80,531
Actual
80,531
Actual
$20.29 billion
Actual
-0.9%
179.61%
$36,615
DEC
1891
2015
Euronext Amsterdam:PHIA
3.0
2.34
2.34
Is this your business? Contact us to understand how D&B calculated your company’s specific ESG Ranking, provide new or updated information to ensure your company’s ESG Ranking remains accurate and up to date, or dispute your current ranking.
Contacts
Get in Touch with 34 Principals*
A D&B Hoovers Subscription is your foot in the door to Koninklijke Philips N.V. contact information.
-
F. A. van HoutenRegistered Principal
-
Marnix Jeroen van GinnekenDirector and Authorised Signatory
-
Abhijit Bhattacharya,Authorised Signatory and Director
-
François A. van HoutenDirector
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2020 (12 month period) in USD
Annual Sales 2021
$20.29 billion
USD
Actual
1 USD = 0.8456 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net Operating Cash | $1,927 | $2,970 | $2,144 |
| Net Investing Cash | -$4,343 | -$1,498 | -$606 |
| Net Financing Cash | -$2,776 | $571 | -$1,963 |
| Net Change in Cash | -$1,168 | $2,195 | -$309 |
| Cash at Beginning of Period | $3,815 | $1,685 | $1,996 |
| Cash at End of Period | $2,724 | $3,815 | $1,685 |
| Capital Expenditure | -$902 | -$1,058 | -$1,125 |
| Assets (mil) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $2,724 | $3,815 | $1,685 |
| Accounts Receivable | $4,209 | $4,645 | $5,386 |
| Inventories | $4,080 | $3,540 | $3,279 |
| Other Current Assets | $1,224 | $1,277 | $836 |
| Asset Summary | |||
| Total Current Assets | $12,237 | $13,277 | $11,187 |
| Tangible Fixed Assets | $3,191 | $3,173 | $3,389 |
| Intangible Assets | $4,318 | $3,546 | $4,099 |
| Total Assets | $36,615 | $32,774 | $31,950 |
| Liabilities (mil) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $2,214 | $2,506 | $2,471 |
| Short-Term Debt | $63 | $109 | $130 |
| Other Current Liabilities | $6,533 | $6,532 | $5,652 |
| Liability Summary | |||
| Total Current Liabilities | $8,809 | $9,146 | $8,252 |
| Long-Term Debt | $5,646 | $5,490 | $4,455 |
| Other Long-Term Liabilities | $66 | $92 | $84 |
| Total Liabilities | $19,498 | $18,700 | $17,019 |
| Stakeholder's Equity (mil) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Equity | |||
| Common Stock | $209 | $215 | $212 |
| Retained Earnings | $ | $ | $ |
| Equity Summary | |||
| Total Equity | $17,075 | $14,038 | $14,898 |
| Shares Outstanding | 870,182,445 | 905,128,293 | 909,047,193 |
Before You Go
Don't miss your chance for 50 free email contacts and prospecting data right inside of your inbox.
Don't miss your chance for 50 free email contacts and prospecting data right inside of your inbox.